W3S1:

A 36-year-old female with ESKD, maintained on HD for three years presented with persistent dry cough for 2 months. Medication review included calcium carbonate 2000 mg orally, and alfacalcidol 0.5 mcg orally per day.  

Review of her routine laboratory work-up revealed:

Test

Value

S. Creatinine

3.9 mg/dL

S. corrected Calcium 

11.52 mg/dL

S. Phosphorus

5.7 mg/dL

iPTH

127 pg/mL

Hemoglobin (Hgb)

10.5 g/dL

A. Interpret the above laboratory investigation.

B.  What would be your next management plan?

 

47 Comments

  • Radwa Ellisy


    1. this patient with ESRD has mild anemia, positive calcium balance, and iPTH below the target according to KDIGO guidelines

    mild hyperphosphatemia and hypercalcemia

    1. restriction of calcium supplementation and use of non-calcium-based binders

    use of low calcium dialysate, and follow up

    if no improvement: investigation for hypercalcemia espicially in the presence of dry cough

    ACE level, Vit D level

  • Rania Mahmoud


    A. Interpret the above laboratory investigation.
    ESRD with hypercalcemia and hyperphosphatemia.
    B. What would be your next management plan?
    stop calcium-containing binders

    • Stop active vit D and calcium carbonate
    • Chest –x ray
    • Use low dialysate calcium.
    • Follow up of ca ,ph , PTH 
    • ACE level to exclude sarcoidosis
    • Start non calcium containing phosphate binders
  • Amna Kununa


    A. Interpret the above laboratory investigation

    Treatment goals in CKD5D:

    • PTH less than 2-9 times upper limit for the PTH
    • Ca: < 9.5 mg/dl
    • Pi: 3.5-5.5 mg/dl

    So: hyperCa, hyperP and PTH is below the target with mild anaemia

    B. What would be your next management plan?

    She is on calcium carbonate 2000 mg per day (800mg elemental Ca).

    • Of note, one gram of calcium carbonate equals 400mg of elemental calcium.
    • Daily elemental Ca intake (dietary and Ca-based phosphate binders) recommendations in CKD IIIa through CKD5 HD/PD vary; KDOQI 2003 recommends not exceeding 2000 mg/day.
    • So do not exceed 3,750 mg/day Ca carbonate (1,500 mg/day elemental calcium).

    index case has hypercalcemia may be a result of:

    • High dietary calcium source
    • medication related/ dialysate
    • pathological disease

    Young female with an unclear underline cause of her ESKD and persistent dry cough, I would like to exclude granulomatous disease (Sarcoidosis, TB and lymphoma).

    My approach:
    Ensure adequate HD with low Ca dialysate
    Dietitian review
    D/C Calcium Carbonate
    Consider non-calcium-based phosphate binder
    Workup for hyperCa:
    Hx (drug Hx very important ) and clinical examination
    Rule out sarcoid, lymphoma and TB (CXR,1,25 vit D and 25 vit D, Sputum AAFB, ACE level, blood film, lymph node bx if exist, etc.).

  • Khaldon Rashed Ahmed Moqbil


    A-ESRD , hyper Ca hyper phos, low PTH, mild anemia
    low turn over MBD
    B- stop calcium
    stop one Alfa 
    use low dialysate calcium.
    CXR
    CT chest
    TB screen
    repate after 3 months PTh and ca phos within 1 month .

  • Rola Kotob


    Interpret the above laboratory investigation.
    ESRF with hypercalcemi and hyperphosphatemia, with low PTH FOR DIALYSIS MIDDLE AGE FEMALE

    What would be your next management plan?
    REVIEW ALL HISTORY AGAIN, DRUG HISTORY
    stop any drug us or interact with ckd mbd drugs
    ask fo full updated Lab results add PTH , bon specific ALK, 2hydroxy vit D level
    x ray for the skull, pelviabd us ,HRCT,

  • Marwa Alm


    ESRD pt, hypercalcemia, hyperphosphatemia, low PTH, possible low turnover bone ds
    next step: stop calcium and alfacalcidol supplements, dialyse against low calcium dialysate, check for 25OH vitamin D, HRCT chest

  • Mohamed Abdulahi Hassan


    ESKD with hypercalcemia and hyperphosphatemia.
    Next management plan
    stop calcium-containing binders
    Cxray
    AFB

  • Mohammed Farag


    Hypercalcaemia, hyperphosphatemia, PTH below optimal level
    Stop Ca based binders
    Stop active vit D
    Use non Ca based binders
    Work up for HYPERCALCEMIA with low PTH

  • Asmaa Salih KHUDHUR


    A. Interpret the above laboratory investigation.
    ESKD , hypercalcimia , hyperphosphatemia, low PTH, mild anemia.
    B. What would be your next management plan?
    stop calcium and start non calcium phosphate binders
    stop one Alfa
    use low dialysate calcium.
    CXR and CT chest
    TB screen
    follow up of ca ,ph , PTH .

  • Hagar Ali


    A)case of hypercalcemia ,hyperphosphatemia and low pTH
    B)stop ca supplement and alfacalcido
    if high ca not improved give non ca containing phosphate binder
    dialysis with low ca dialysate(1.25) can improve ca and pth level
    measure PSALP
    chest Xray for her chest problem

  • Ahmed Altalawy


    A. Interpret the above laboratory investigation.
    ESRD- Hpercalcemia- Hyperphosphatemia – Low PTH
    B. What would be your next management plan?
    1-Stop calcium carbonate and alphacalcidol
    2-Start non calcium containing phosphate binders.
    3- Low calcium dialysate.
    4- chest X ray.
    5- Measure Vitamin D level and ACI level .

  • HASSAN ALYAMMAHI


    Lab investigations show hypercalcemia and hyperphosphatemia, the iPTH is within the recommended range, Hb is slightly lower than recommended

    Since he has hypercalcemia, I would look for causes of hypercalcemia, and since he is coughing then he may have TB or Sarcoid (contributing to hypercalcemia)
    so CXR / HRCT / Sputum culture and AFB / and serum ACE
    I will have to stop his CaCO3 and VitD3

  • Alaa Abdel Nasser


    Lab investigations show:hypercalcemia,hyperphosphatemia,accepted PTH level(2 times more than the normal range) and anaemia(HB level accepted for patient on CHD)

    What would be your next management plan?
    1-Stop calcium carbonate and alphacalcidol
    2-if serum phosphorus is not improving, start non calcium containing phosphate binders(sevelamer)
    3- Check drugs that cause cough like ACEI, ARBS and omperazole.
    4- chest radiology to exclude any chest radiology .
    5- Measure Vitamin D level
    6-Follow up serum ca ,po4, and PTH.

  • MOHAMMED HAJI HASSAN


    Interpret the above laboratory investigation.

    ESRD- Hpercalcemia- Hyperphosphatemia- Anemia

    What would be your next management plan?

    Cough: rule out TB and sarcoidosis by CXR, sputum AFBx3, and sputum C/S, and ACE level.
    Stop the Calcium and Vitamin D
    Monitor PTH , calcium and vitamin D level

  • Mahmoud Elsheikh


    • Hypercalcemia/Hyperphosphatemia.
    • Low PTH
    • Anemia.

    …

    • Stop calcium tablet.
    • Investigate for chest pathology.
    • good dialysis.
    • VitD level.
    • Sevelamer/Cinacalcet.
  • Asma Aljaberi


    A. Interpret the above laboratory investigation.
    ESRD with Hypercalcemia, hyperphosphatemia, hyperparathyroidism, and anemia.
    B. What would be your next management plan?
    As I don’t have much info about the reason for ESRD in this young patient, and in view of hx of persistent cough for 2 months, and taking into consideration the biochemical parameters results, I would investigate for granulomatous disease in such patient.
    I would explain my thought process, young female with ESRD and chronic cough, could be sarcoidosis. Sarcoidosis might started years back, with hypercalcemia, she might had long standing nephrolithiasis, leading to nephrocalcinosis, with/or without interstational nephritis, which eventually resulted in ESRD. If I continue to believe in Sarcoidosis as a primary disease, that means her 1-25 Vit D is high, due to increase activation of 1-alpha hydroxylase in the abundant macrophages. High 1-25 vit D, increases intestinal absorption of Ca, and PH.
    Other cause of granulomatous disease, TB. It could be that this patient is having TB due to her immunocompromised status. Since TB is granulomatous disease too, and has high number of macrophages. The 1-25 VitD would increase and Ca, and PH would increase too due to high intestinal absorption. 
    I would stop Ca, and alfacalcidol.
    I would order CXR, sputum AFBx3, and sputum C/S, and ACE level.
    I would check if the patient has any skin lesion, or lymph node which could be biopised as sometimes if would be difficult to reach such diagnosis.

  • KAMAL ELGORASHI


    Interpretation of the result

    • Hypercalcemia.
    • Hyperphosphatemia.
    • Supressed PTH, (medication side effects)
    • Anemia.

    Plan

    • D/C calcium tablet.
    • Workup underline chest pathology.
    • Optomise dialysis.
    • Estimate VitD level.
    • Sevelamer.
    • Cinacalcet.
  • Riaan Flooks


    A: The patient is having CKD – Stage 5 (on RRT), with Hypercalcemia, Hyperphosphatemia, Anemia and an elevated PTH

    B: Cough:
    Enquire about constitutional symptoms ( night sweats, hemoptysis, LOA, LOW,
    dyspnoea, PND, orthopnoea, etc)
    Enquire about smoking – possible risk factor for Ca lung
    Enquire about any other meds that patient is using, esp ACE-inhibitors
    Investigations:
    CXR + CT Chest: evaluate lung fields and mediastinum
    Echocardiogram: exclude any cardiac causes for coughing
    Serum ACE for Sarcoidosis

    Biochemical abnormalities:
    The abnormalities seen with the Calcium and Phosphate is most probably driven
    by her current meds: Vitamin D and Calcium-containing phosphate binder – STOP
    the meds, and change onto a Non-Calcium containing phosphate binder.
    Improve/educate patient on low phosphate containing foods
    Monitor the Ca, PO4 and PTH – in order to restart the Vit D

  • Rabab ALaa Eldin keshk Rabab


    A- interpretation of investigation hypercalcimia, hyperphosphatemia,high pth level and anemia.
    B- management plane stop vit d and ca and follow up and do chest x-ray to detect the cause of cough

  • Mahmud ISLAM


    Ca load from phosphorus binding Ca Carbonate together with active vitamin D plays a role in hypercalcemia. Stopping calÅŸcitriol and shifting to sevelamer or low-dose Lantanum will help decrease calcium load and phosphorus absorption minimally increase with active vitamin D. After PTH returns to around 300, we may restart the lower dose of Calcitriol.

  • Elsayed Ghorab


    female pt. 36y/o esrd on regular HD since 3y on caco3 200mg and alfacalcidiol 0.5 mic
    lab investigation revealed :-
    anemia
    hypercalcemia
    hyperphosphatemia
    suppressed iPTH
    Action plan :-
    should be stop ca phosphat binder ca carbonate and shifting to non ca phosphate binder
    and stop alfacalcdiol
    and search about dry cough review the medication exclude ACEI
    investigate pt. for dry cough and 2ry hypercalcemia
    chest x-ray to rule out TB
    Follow up and observation

  • Rihab Elidrisi


     Interpret the above laboratory investigation.
    This patient is having ESRD on HD with new onset of chronic cough along with hypercalcemia and hyperphosphatemia and low iPTH .

    Her Hb is low compared to her age (non-menopausal age)

    The cause of High Ca is the use of Ca supplements along with the use of Vita AND both of them will lead to high Ca and high Phosphorous and this will lead to suppressing the PTH level. This patient is most likely having a low turnover bone disease.

    What would be your next management plan?

    I would stop the Ca supplement and Vitamin. D and will start non-Ca binder phosphates on the same time I will start to work her up for her dry cough by doing full investigation which includes chest x ray and further chest assessment to rule out secondary causes for hypercalcemia.

  • Abdulrahman Almutawakel


    PATIENT IS ESKD ON HD MOSTLIKLY HE HAS ADEQUATE DIALYSIS , MILDY ANEMIC , SHE HAS HYPERCALEMIA AND HYPERPHOSPHATEMIA MOSTLY DUE TO OVER TREATMENT , NEEDS TO STOP CALCIUM AND ALFACALCIDOL ADD PHOSPHATE BINDER NONCALCIUM CONTAINING . DIALYSIS WITH LOW CALCIUM DIALYSATE 1.5-2.0 OR EVEN LOWER BUT FOR SHORT PERIOD , TO AVOID BONE DEMINERALIZATION. DETAILED HISTORY AND MEDICATION HISTORY , THEN GO FOR FURTHER INVESTIGATION FOR HER COUGH STARTNIG WITH MEDICATION HISTORY , CXR , PULMONOLOGY CONSULTATION AND

  • Muhammad Soobadar


    management plan
    stop caco32- and alfacalcidol for some time and review with repeat bloods
    cxr
    1-25 oh levels
    ace levels
    ca dialysate 1.25

  • Muhammad Soobadar


    interpret above laboratory investigation?
    CKD 5D
    anaemia of ckd likely
    hypercalcaemia on calcium carbonate and alfacalcidol
    pth 127 ( Possibly suppressed)
    In context of chronic cough need to rule out tb/sarcoid

  • Ben Lomatayo


    A. Interpret the above laboratory investigation.

    • High creatinine
    • Anemia
    • Hypercalemia
    • +ve calcium balance
    • Hyperphopatemia
    • Low iPTH
    • These findings are most likely due to side effect vit D & calcium & supplementation.

    B. What would be your next management plan?

    *Differential diagosis of cough in this patient

    • Take more history, e.g,. weight loss, night sweats, loss of appetite lumps & bumps.
    • This had persistent cough in the history; cough and hyperglycemia, I would like to rule out sacroidosis or malignancy such as Ca lung
    • Pulmonary tuberculosis as to be excluded
    • I will review his drugs; because ACE-i may cause dry cough

     
    Further investigations

    • CXR for masses, infiltrates
    • HRCT for lymhadenothapies, interstitial changes
    • Lateral abdominal X ray to look for vascular calcification
    • Echo for vascular calcications
    • Total ALP or bALP
    • Serum ACE level
    • Repeat serum calcium

    Interventions

    • Stop calcium and vitamin D supplementation
    • Review the dialysate Ca and keep it at 1.25 mmol/l by now
    • Consider non calcium based phosphate binders e.g. sevelamer carbontae
    • Dietary intervention to control hyperphosphatemia
    • Monitor Ca, PO4, iPTH frequently
    • You may consider osteoanabolic therapy if no improvement and the patient became symptomatic (may be debatable in dialysis patient)

    Put her a transplant list

  • Mark Nagy Zaki Amin Mark


    A- A case of ESRD with average s.cr with hypercalcemia ,hyperphosphatemia with suppressed iPTH ( mostly low turnover bone disease) caused by over treatment with calcium and active vit D in addition to normal Hgb as compared to the target value for this population .
    B- management plan
    1-stop calcium supplemention immediately
    2-use of non calcium containing po4 binders instead of calcium containing
    3- stop vit D to increase iPTH and decrease hyperphosphatemia
    4- Dietary phosphate restriction with the help of po4 pyramid
    5- use the least ca dialysate concentration (1.25 mmol)
    6- use of nocturnal prolonged daily HD if still persistant high po4

    • Rasha Samir


      Well done! however, the best dialysis regimen for controlling hyperphosphatemia needs further exploration. It is likely that short frequent rather than prolonged sessions is more effective. Ofcourse, longer dialysis can remove more but at slower rate.

  • Israa Hammoodi


    A. CKD stage 5, hypercalcimia, hyperphosphatemia, low PTH, anemia
    B. need the following investigation
    Bone specific alkaline phosphotase, 1,25 vitD, 25 vit D, iron study, chest x-ray
    Patient need to stop calcium tab. And alfa calcidol and give him non calcium containing phosphate binders

  • Ashraf Ahmed Mahmoud


    Interpret the above laboratory investigation.

    • CKD- 5 D.
    • hypercalcemia, hyperphosphatemia low target PTH (suggested adynamic bone disease.)

    B. What would be your next management plan?

    1. review the the dry weight of patient ( may be volume overload with increase abdominal pressure causing cough )
    2. stopping calcium supplementation and alfacalcidol.
    3. abd x ray lat view.
    4. Chest X ray.
    5. follow- up of bone Alkaline phosphatase . calcium ; phosphorus, PTH and .25 OH vitamin D.
  • Nour Al Natout


    A. Hypercalcemia , hyperphosphatemia , secondary hyperparathyroidism.

    B.switch calcium carbonate to non calcium containing phosphate Binders( like sevelamer or lanthanum) .
    Stop calcitriol.

    Measure 1,25 OH vitamin D and 25 OH vitamin D.
    HD with Dialysate 1,25 Ca
    CXR(lymphadenopathy?) , AP, LDH ,if possible rPTH, serum electrophoresis.

  • Weam El Nazer


    A. Interpret the above laboratory investigation.

    ESRD on HD with mild hypercalcemia and mild hyperphosphatemia and low normal iPTH
    the impression is an adynamic bone disease(iatrogenic)

    B. What would be your next management plan?
    stop calcium and one alfa
    follow-up the level of Ca, po4,iPTH,25-OHvit-D, and ALK.phosphatase(bone-specific)
    Lateral ABD-XR and Echo
    If persistent hypercalcemia, dialysis against low path Ca. and start workup for hypercalcemia.

  • Emad mohamed mokbel Salem


    A-
    CKD G5D
    mild hypercalcemia
    hyperphosphatemia
    inappropriately low PTH(target on dialysis 150–450 pg/l)
    hemoglobin level within target
    ==========================
    B:
    1-HOLD CALCIUM AND ALFACALCIDOL
    2-DIALYSIS WITH DIALYSATE CALCIUM 1.25 MMOL/L
    3-FULL HISTORY AND EXAMINATION TO R/O MALIGNANCY ,SARCOIDOSIS ,
    4- LAB
    1-rPTHpALKALINE PHOSPHATASE
    2-1,25(OH)D3
    3-CXR ,HRCT,ACE
    4-TFT

    ===========

  • Ibrahim Omar


    A. Interpret the above laboratory investigation.

    • CKD- 5 D.
    • within target Hb %
    • hypercalcemia, hyperphosphatemia and inappropriately low PTH …… adynamic bone disease.

    B. What would be your next management plan?

    • stopping oral calcium and alfacalcidol.
    • maintaining euvolemic status.
    • Chest X ray for possible granuloma
    • follow- up of serum calcium & phosphorus, PTH
    • if not controlled, check 1,25 Vit. D level.

Leave a Reply

You cannot copy content of this page